Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

OR-HMC

Financiado

Assay for cancer diagnostics by quantification of 5hmC

Assay for cancer diagnostics by quantification of 5hmC 5-hydroxymethylcytosine (5hmC) is a modified form of the DNA base cytosine and is an important epigenetic marker linked to regulation of gene expression in development and tu... ver más

31/01/2019

TAU

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

TEL AVIV UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-01-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2017-PoC: ERC-Proof of Concept

I+D

Cerrada hace 7 años

0% 100%

2 Participantes

TAU

150.00K€ | Lider

IZURZA PRODUCTOS CALORIFUGOS

Proyectos interesantes

EpiCblood Towards early cancer detection and tumor classification usin... 1M€ Cerrado

EpiDetect Detecting epigenetic biomarkers in the blood for non-invasiv... 2M€ Cerrado

EQC2018-004733-P ADQUISIÓN DE EQUIPO PARA IDENTIFICACIÓN Y RECUPERACIÓN DE CÉ... 171K€ Cerrado

EQC2021-006895-P Espectrómetro de masas para la medida multiparamétrica simu... 525K€ Cerrado

EPIPHARM Development of a ncRNA DNA Methylation Kit for Treatment Gui... 149K€ Cerrado

EpiCancer Comprehensive Platform for the Functional Characterization o... 2M€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 18 meses Fecha Inicio: 2017-07-11
Fecha Fin: 2019-01-31

Líder del proyecto

TEL AVIV UNIVERSITY

TRL 4-5

Presupuesto del proyecto 150K€

Descripción del proyecto Assay for cancer diagnostics by quantification of 5hmC 5-hydroxymethylcytosine (5hmC) is a modified form of the DNA base cytosine and is an important epigenetic marker linked to regulation of gene expression in development and tumorigenesis. The loss of 5hmC is observed across a wide spectrum of malignant tumours. The goal of the proposed project is to utilize a novel chemo-enzymatic labelling scheme developed within the framework of my ERC project in order to develop a high-throughput assay capable of quantifying 5hmC levels for cancer diagnostics. We have developed a spectroscopic method for global quantification of 5hmC in genomic DNA, which can be performed in multi-well plates for high throughput analysis, or on individual DNA molecules for ultimate sensitivity. We aim to combine these two approaches and further develop a simple and rapid multi-well slide assay which measures 5hmC levels in DNA, and combines both high throughput and high sensitivity. This slide will be compatible with a standard microarray scanner, lowering the development barriers for commercialisation of specific diagnostic applications. In parallel, we aim to establish the relationship between 5hmC levels in colorectal cancer and the state of disease. Preliminary results show significant decrease of 5hmC in colorectal cancer samples relative to that of healthy colon. This assay will potentially offer earlier diagnosis of cancer as well as means for easy monitoring of disease and response to treatment. The project aims to establish preliminary analysis of colorectal cancer samples but the general approach may be directly extended to other types of malignancies.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores